XML 41 R27.htm IDEA: XBRL DOCUMENT v3.25.3
Insider Trading Arrangements
 3 Months Ended 12 Months Ended
Sep. 30, 2025
shares
Sep. 30, 2025
shares
Trading Arrangements, by Individual    
Non-Rule 10b5-1 Arrangement Adopted false  
Rule 10b5-1 Arrangement Terminated false  
Non-Rule 10b5-1 Arrangement Terminated false  
Thomas E. Polen [Member]    
Trading Arrangements, by Individual    
Material Terms of Trading Arrangement
On August 13, 2025, Thomas E. Polen, Chairman, Chief Executive Officer and President of BD, adopted a trading plan intended to satisfy the conditions under Rule 10b5-1(c) of the Exchange Act. Mr. Polen’s plan is for: (i) the exercise of up to 47,700 stock appreciation rights (“SARs”) at various exercise prices, net of shares withheld to satisfy applicable taxes. The sales will be made in accordance with the prices and formulas set forth in the plan and such plan terminates on the earlier of the date all the shares under the plan are sold and December 1, 2026.
  
Name Thomas E. Polen  
Title Chairman, Chief Executive Officer and President of BD  
Rule 10b5-1 Arrangement Adopted true  
Adoption Date August 13, 2025  
Arrangement Duration   475 days
Aggregate Available 47,700 47,700
Michael Garrison [Member]    
Trading Arrangements, by Individual    
Material Terms of Trading Arrangement
On August 13, 2025, Michael Garrison, Executive Vice President and President, Medical Segment of BD, adopted a trading plan intended to satisfy the conditions under Rule 10b5-1(c) of the Exchange Act. Dr. Garrison’s plan is for: (i) the exercise of up to 3,054 SARs at various exercise prices, net of shares withheld to satisfy applicable taxes, (iii) the sale of up to 999 shares of BD’s common stock upon the vesting of time vested units (“TVUs”), net of shares withheld to satisfy applicable taxes, and (iv) the sale of up to 4,063 shares of BD’s common stock upon the vesting of performance units, subject to the final payout factor and net of shares withheld to satisfy applicable taxes. The sales will be made in accordance with the prices and formulas set forth in the plan and such plan terminates on the earlier of the date all the shares under the plan are sold and December 3, 2026.
  
Name Michael Garrison  
Title Executive Vice President and President, Medical Segment  
Rule 10b5-1 Arrangement Adopted true  
Adoption Date August 13, 2025  
Arrangement Duration   477 days
Michael Garrison Trading Arrangement, Stock Appreciation Rights [Member] | Michael Garrison [Member]    
Trading Arrangements, by Individual    
Aggregate Available 3,054 3,054
Michael Garrison, Trading Arrangement, Common Stock Upon The Vesting Of Time Vested Units [Member] | Michael Garrison [Member]    
Trading Arrangements, by Individual    
Aggregate Available 999 999
Michael Garrison, Trading Arrangement, Common Stock Upon The Vesting Of Performance Units [Member] | Michael Garrison [Member]    
Trading Arrangements, by Individual    
Aggregate Available 4,063 4,063